This site is intended for healthcare professionals
Drug news

Interim results from the ABOUND clinical trial program of Abraxane (paclitaxel protein-bound particles for injectable suspension) for advanced NSCLC. - Celgene

Read time: 1 mins
Last updated:28th Jun 2017
Published:7th Dec 2016
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest